United Therapeutics(UTHR.US) Officer Sells US$2.27 Million in Common Stock

$United Therapeutics(UTHR.US)$ Officer ROTHBLATT MARTINE A sold 7,200 shares of common stock on Jul 5, 8, 2024 at an average price of $315.1507 for a total value of $2.27 million.Source:

Futu News05:10

Citi Research's AI Hedge Stocks - Part II

Seeking Alpha01:22

Unveiling 6 Analyst Insights On United Therapeutics

United Therapeutics (NASDAQ:UTHR) underwent analysis by 6 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.The table below offers a condensed view of their rece

BenzingaJul 9 02:01

United Therapeutics Is Maintained at Buy by UBS

United Therapeutics Is Maintained at Buy by UBS

Dow JonesJul 9 00:05

UBS Maintains Buy on United Therapeutics, Raises Price Target to $370

UBS analyst Ashwani Verma maintains United Therapeutics (NASDAQ:UTHR) with a Buy and raises the price target from $300 to $370.

BenzingaJul 8 23:55

United Therapeutics Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/08/2024 16.91% UBS $300 → $370 Maintains Buy 06/12/2024 10.6% Wells Fargo $325 → $350 Maintains Overwei

BenzingaJul 8 23:51